Abstract
AbstractDuring the Thirty First World Health Assembly of the World Health Organization, Resolution WMA 31.32 on the Action Programme on Essential Drugs which recognized the importance of an adequate supply of essential drugs and vaccines to meet the real health needs of people living in developing countries was passed. The resolution also recognized the legitimate aspiration of developing countries to establish local production of those essential drugs wherever feasible.In implementing the resolution, the WHO has called a meeting of its Expert Committee on the Selection of Essential Drugs in October 1977. The report of that Meeting resulted in a model list of essential drugs which appeared in the WHO Technical Report Series 615.Continuing its efforts to fully implement WHA 31.32, the WHO has called the Meeting on Drug Policies: formulation and dosage forms and in-process quality control of essential drugs in developing countries in April 1979. The meeting discussed recommendations on criteria for the deve...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
